You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Algeria

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Algeria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Algeria, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Algeria for free:

The Consumer Health in Algeria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Algeria?
  • What are the major brands in Algeria?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Healthy OTC performance fuelled by increased disposable incomes

OTC categories witnessed strong growth. Certain categories maintained increasing growth, whereas others, which face competition from prescription drugs, witnessed slowdowns. Despite rising prices, growth was maintained thanks to increasing disposable incomes, particularly in large cities where OTC categories generate the largest value sales

Decrease in self-medication due to better social security

The development of the social security card, Chifa, which allows direct refund in pharmacies for prescribed drugs, has led to a decrease in self-medication as consumers prefer to go through a doctor to receive a prescription. However, self-medication remains strong for certain OTC categories, particularly cough and cold products and digestive remedies. For these products no refund is available, and consumers tend to know what they want to buy.

Illegal advertising on Algerian media allows better performance for international brands

Advertising drugs via any media format is banned in Algeria, except with special authorisation of the Ministry of Health. As a consequence, domestic laboratories face unfair competition from international brands, which gain from advertising on foreign TV channels, particularly French satellite channels widely watched in Algeria. Moreover, Algerian consumers remain more confident in French brands and hardly Algerian brands or locally produced generics due to a lack of trust in the quality of the latter.

Pharmacies remain the leading distribution channel

Pharmacies remain the main distribution channel in Algeria, and the unique channel for OTC drugs. Other distribution channels, such as grocery retailers, gain sales in few categories such as wound care, but in small proportions. All OTC drugs are available over the counter only, and not placed for self-service, with the pharmacist offering product according to clients’ needs.

Development of domestic production expected to increase OTC sales

The government is encouraging domestic producers by continuously increasing the number of drugs banned from import in order to give a greater advantage to local laboratories. Over the forecast period imports are expected to strongly decrease and become a minority among OTC categories. Moreover, the law authorising domestic laboratories to be their own distributor will allow better expansion of local production and less competition with imports.

Table of Contents

Table of Contents

Consumer Health in Algeria - Industry Overview

EXECUTIVE SUMMARY

Healthy OTC performance fuelled by increased disposable incomes

Decrease in self-medication due to better social security

Illegal advertising on Algerian media allows better performance for international brands

Pharmacies remain the leading distribution channel

Development of domestic production expected to increase OTC sales

KEY TRENDS AND DEVELOPMENTS

Government-owned Saidal and private manufacturers partially encouraged to increase production

Improvement of social security decreases self-medication

Ban on media advertising for medicines gives advantage to international brands

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Algeria - Company Profiles

Biopharm Algérie SPA in Consumer Health (Algeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Biopharm Algérie SPA: Competitive Position 2010

Magpharm Laboratoires in Consumer Health (Algeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Magpharm Laboratoires: Competitive Position 2010

Saidal Algerie SPA in Consumer Health (Algeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Saidal Algérie SPA: Competitive Position 2010

Adult Mouth Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care registered a 6% current value terms increase in 2010 – a healthy performance resulting from rising oral hygiene awareness. Sales are essentially generated by upper- and middle-income consumers, who are already aware of the products and willing to pay even if prices increase. However, lower-income consumers continue using traditional methods such as clove in the case of toothache, liquorice for bacteria causing bad breath, and souak, a walnut bark for similar usage as toothbrush and toothpaste.

SWITCHES

COMPETITIVE LANDSCAPE

  • GSK led with 29%, followed by Pfizer on 27%. Despite remaining a key player, Pfizer Algérie SPA saw a strong decrease in value in 2010, losing sales to several small brands also produced domestically, and which are giving consumers a greater choice.

PROSPECTS

  • Adult mouth care is expected to see a weak 1% constant value CAGR over the forecast period. Prices are expected to decline to become affordable to more consumers.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Algeria - Category Analysis

HEADLINES

TRENDS

  • OTC analgesics registered 10% current value growth in 2010 – a strong performance that indicates that self-medication remains strongly present, even if it is slowly losing out to prescription drugs due to improved social security refunds. 2010 witnessed the strong growth of combination analgesics and acetaminophen. Both categories are replacing aspirin usage, which is increasingly discouraged by doctors, except in relation to specific diseases.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis Algérie SPA was the key player in 2010, holding a 28% value share. The international company has a manufacturing plant in Algeria, and produces prescription medicines, vaccines, generic medicines and over-the-counter medicines. Its OTC generics are advertised on French TV, which gives it a strong advantage, particularly because Algerian consumers have a preference for French brands.

PROSPECTS

  • The analgesics category is expected to see a 4% constant value CAGR over the forecast period. The healthy performance is due to maintained demand for acetaminophen. This will be boosted by the recently emerged category of combination analgesics, as well as demand for analgesics to treat urgent medical needs such as toothache and other pain.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Algeria - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products witnessed 11% value growth in 2010, mainly due to the development of child-specific products. As a result of high prices in the category, sales remain mainly limited to upper-income consumers, who are investing the most in their health and their babies’ health.

SWITCHES

COMPETITIVE LANDSCAPE

  • International player Boiron was the leader at the end of the review period, holding a 25% value share. The company exports its products to Algeria and encounters high demand with the leading product, Valerian. The product is known by the majority of consumers who buy calming and sleeping products, and is the product most frequently advised by pharmacists, because it has been present in Algeria for a long time.

PROSPECTS

  • The category is expected to register a 5% constant value CAGR over the forecast period. Healthy growth will be underpinned by the development of the category and the number brands available. Furthermore, the development of child-specific products is expected to maintain volume sales at steadily increasing rates.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies registered 10% value increase in 2010, a strong performance revealing maintained demand for products in this category. Cough, cold and allergy remedies did not suffer the same competition from prescription drugs and significant shortages as other categories.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saidal Algerie SPA remained the key player in cough, cold and allergy (hay fever) remedies at the end of the review period, holding a 36% value share. The state-owned domestic company produced several international brands under licence, and is developing several generic brands to sell to lower income consumers.

PROSPECTS

  • The cough, cold and allergy (hay fever) remedies environment is expected to see a healthy 5% constant value CAGR over the forecast period. Higher buying power and better refunds for prescription drugs will allow increased expenditure on OTC drugs, particularly in this category, as such products are rarely purchased after a medical consultation due to being considered minor illnesses.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Algeria - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies witnessed 14% current value terms growth in 2010, which was the strongest rate among consumer health products. The fast growth was a result of a rise in prices in this category which does not witness competition from prescription digestive remedies. This is the category which sees more frequent purchases in emergency cases, with products bought simply with the pharmacist’s advice.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saidal Algerie SPA led sales in 2010 generating a 41% value share. The domestic company produces several international brands under license, such as Forlax and Imodium, which are among the best-selling brands in the category, and witnessing increases as the government is increasingly banning imports to encourage domestic production.

PROSPECTS

  • Digestive remedies is expected to witness an 8% constant value CAGR over the forecast period. The solid growth rate is expected to be the result of the development of the category, with more brands becoming available, particularly through domestic production. Moreover, rising buying power and a rich daily diet is likely to lead to increasing digestive problems.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Ear care witnessed a healthy 6% current value terms increase in 2010. Sales were generated essentially by higher income consumers, as lower consumer segments prefer traditional homemade remedies, such as simple warm water with salt. If the case is serious consumers obtain a prescription.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoire de Diagnostic Maghrebin (LDM Groupe) was the leader, generating a 24% value share at the end of the review period. The company manufactures in Algeria the brand Cerulyse under license from large international company Bausch & Lomb, and this was the best performing brand in 2010.

PROSPECTS

  • Ear care is expected to see a low 1% constant value CAGR over the forecast period. The weak rate is the result of rising competition from prescription medicines, for which consumers pay at small price in pharmacies, rather than paying more for OTC ear care products.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Eye care witnessed a 6% current value terms increase in 2010 – a healthy performance underpinned by increased unit prices. However, consumer demand was maintained thanks to increased buying power and rising health awareness, with consumers using more standard OTC medicines than homemade traditional remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Algérie SPA was the key player in 2010 generating a 37% value shares. The company manufactures the best performing brand: Vitabact. This is in the standard price segment, and affordable to the majority of consumers.

PROSPECTS

  • Eye care is expected to register a weak constant value CAGR of less than 1% over the forecast period. The category is expected to face strong competition from prescription medicines with the rise of Chifa card refunds, and because it is a category where consumers feel the need to obtain medical advice, particularly as prices are expected to increase.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Algeria - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products witnessed greater demand from consumers switching from homemade/traditional products but do not want to use standard medicines, who found this category offers a good compromise. The category witnessed 6% value growth in 2010, resulting from an increase in prices in an environment that faces a lot of illegal trade from Chinese teas.

COMPETITIVE LANDSCAPE

  • The herbal/traditional products category was fragmented in 2010. Few companies, such as Laboratoire Phyto and Laboratoire Juva Santé have visible products in pharmacies, but they do not generate sufficient share at total category sales.

PROSPECTS

  • Herbal/traditional products are expected to register a minor 2% constant value CAGR over the forecast period. Prices are expected to decline as manufacturers seek to attract consumers who currently use homemade solutions or buy illegal products. However, the expected decline in standard OTC categories will retain more sales, and consumers will still associate standard OTC products with greater efficiency than soft herbal/traditional products.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Increasing buying power and health awareness led to a solid 9% current value terms increase for medicated skin care in 2010. The category mainly comprises international brands, and despite high prices pharmacies are witnessing increasing demand and a larger product offer, leading to healthy growth rates.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic company Saidal Algerie SPA led medicated skin care in 2010, generating a value share of just over 12%. The domestic company registered a strong performance, essentially among topical and vaginal antifungals, the latter being the best-selling category.

PROSPECTS

  • Medicated skin care is expected to witness a 4% constant value CAGR over the forecast period. The healthy growth is expected to be the result of an increase in medicated skin care demand. Some categories will benefit from rising health and beauty awareness, such as acne treatments and medicated shampoos.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Algeria - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition remained a niche category targeting specific consumers. The category witnessed a 5% current value terms increase in 2010, and imported brands are standard price brands and sportsmen and women from every income group can afford such products. They continue to be sold mainly through specialised shops, and can occasionally be found in pharmacies in large cities.

COMPETITIVE LANDSCAPE

  • Ultimate Nutrition was the leader in 2010, generating a 30% value share, followed by Optimum Nutrition and Megamax Wellness, generating 18% each. As category sales remain low and the target consumer group limited, companies generate sales according to the number of products available. Whether they also distribute through pharmacies to diversify their potential consumers, or remain focused on sports nutrition specialist retailers, is also a factor.

PROSPECTS

  • Sports nutrition specifically targets a precise niche, and will remain associated with bodybuilders and power-lifters. As a result volume growth is not expected to increase strongly, and value growth will drop to a 1% CAGR over the forecast period.

CATEGORY DATA

  • Summary 9 Sports Nutrition: Brand Ranking by Format 2010
  • Table 66 Sales of Sports Nutrition: Value 2005-2010
  • Table 67 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 68 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 69 Sports Nutrition Company Shares 2006-2010
  • Table 70 Sports Nutrition Brand Shares 2007-2010
  • Table 71 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 72 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Algeria - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements witnessed solid 9% value growth in 2010. The category’s variety of products and brands expanded, with demand growing thanks to advertising on French TV channels, and the influence of western trends and rising dietary awareness. However, at national level vitamins and dietary supplements did not witness any public health campaigns or product promotions.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Domestic manufacturer and distributor Alpharm Srl was the key player in 2010, generating a 26% value share, followed by French company Laboratoire Juva Santé with a value share of 13%. The former company generated sales as a result of its strong presence in dietary supplements, whereas the latter is the leader in vitamin categories.

PROSPECTS

  • The vitamins and dietary supplements category is expected to witness a 4% constant value CAGR over the forecast period. A decrease in prices and market saturation at the end of the forecast period are expected to lead to weak growth. Despite declining prices, there will still be no economy brands, and sales will not be able to reach the large group of low income earners.

CATEGORY DATA

  • Table 73 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 74 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 75 Dietary Supplements by Positioning 2006-2010
  • Table 76 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 77 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 78 Vitamins Brand Shares 2007-2010
  • Table 79 Dietary Supplements Brand Shares 2007-2010
  • Table 80 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Algeria - Category Analysis

HEADLINES

TRENDS

  • The weight management category remained limited to upper-income buyers at the end of the review period, with the large majority being women. The category witnessed 11% value growth in 2010. A strong influence from western and fashion trends, with increasing interest in health and beauty issues is strengthening demand in large cities in Algeria. Even middle-income consumers who cannot afford standard weight management supplements will buy more affordable products such as slimming teas.

COMPETITIVE LANDSCAPE

  • Ultimate Nutrition, Les 3 Chênes and Magpharm Laboratoires are the three key players in weight management, generating 21%, 17% and 10% value shares respectively. The three companies generate their sales in weight loss supplements and other slimming products. However, the only target is upper-income consumers. The exception is Protein Fat Burner sold by Ultimate Nutrition, which offers standard prices and generates sales among both men and women.

PROSPECTS

  • Weight management is expected to witness a 7% constant value CAGR, representing the best-performing OTC category over the forecast period. The international trend of slim means healthy and beautiful is expected to change Algerian habits, not only among upper-income consumers but a larger proportion of the population. Awareness of health and physical conditions is also expected to increase.

CATEGORY DATA

  • Table 82 Sales of Weight Management by Category: Value 2005-2010
  • Table 83 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 84 Weight Management Company Shares 2006-2010
  • Table 85 Weight Management Brand Shares 2007-2010
  • Table 86 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 87 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Wound care registered a solid 7% value increase in 2010. An increasing number of consumers are buying products from this category instead of using simply cotton to cover a wound. Prices are becoming increasingly affordable, and even sticking plasters are witnessing healthy growth due to more affordable prices, whereas only a few years ago only upper-income consumers could afford products in this category.

COMPETITIVE LANDSCAPE

  • Paul Hartmann Algerie Sarl remained the key player in 2010 with a 52% value share. The company has been present in Algeria for several years, and its brands Hartmann and Grassolind are available in the majority of pharmacies. They are also widely known by consumers, who tend to remain loyal to the brands.

PROSPECTS

  • Wound care is expected to witness a minor 2% CAGR over the forecast period. Slow value growth is expected to be due to a drop in prices, but although products will be affordable to the majority, many consumers are not expected to be willing to pay for such offerings, instead continuing to use simple traditional wound care options such as cotton and cloth.

CATEGORY DATA

  • Table 88 Sales of Wound Care by Category: Value 2005-2010
  • Table 89 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 90 Wound Care Company Shares 2006-2010
  • Table 91 Wound Care Brand Shares 2007-2010
  • Table 92 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 93 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Future Demographic

      Consumer Lifestyle

      Country Report